<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>Diamond不是王老五 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-02T20:40:30+08:00</updated>
  <subtitle>定期更新免疫肿瘤数据、机制等，以及个人喜欢并翻译的外文书籍。本公众号文章均为原创，仅代表个人观点，与所供职公司无关，仅做学术交流，无任何商业目的</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>信达肝癌幻灯分享</title>
    <updated>2020-12-02T09:44:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/yWkCna7JMxDfAe6UUvzIjw</id>
    <link href="https://mp.weixin.qq.com/s/yWkCna7JMxDfAe6UUvzIjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 ESMO ASIA：如何应对三代EGFR-TKI耐药</title>
    <updated>2020-11-30T06:45:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/5hgS-BuUpjq10lz3DlUl9A</id>
    <link href="https://mp.weixin.qq.com/s/5hgS-BuUpjq10lz3DlUl9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>对标罗氏，信达的肝癌组合疗效如何？</title>
    <updated>2020-11-22T12:20:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/rHWtEOEj4qYGbq2MZYg7Tw</id>
    <link href="https://mp.weixin.qq.com/s/rHWtEOEj4qYGbq2MZYg7Tw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>疾病进展或死亡风险降低50%！基石公布舒格利单抗NSCLC详细数据</title>
    <updated>2020-11-21T18:16:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-21:/s/zmwE_3sYk_Bzmxtp9Nzf-w</id>
    <link href="https://mp.weixin.qq.com/s/zmwE_3sYk_Bzmxtp9Nzf-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今天从TIGIT谈起</title>
    <updated>2020-11-01T10:28:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/KaganSfFBXDBrWkWBzCT1w</id>
    <link href="https://mp.weixin.qq.com/s/KaganSfFBXDBrWkWBzCT1w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重新审视PD-1通路</title>
    <updated>2020-10-11T19:16:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-11:/s/yCA8COVy-xXJqNqDxGj5Sw</id>
    <link href="https://mp.weixin.qq.com/s/yCA8COVy-xXJqNqDxGj5Sw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ESMO启示：免疫联合同步放化疗是否一定有效？</title>
    <updated>2020-10-01T11:14:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-01:/s/IxFmZ5Jw80T5-xxzenRbBA</id>
    <link href="https://mp.weixin.qq.com/s/IxFmZ5Jw80T5-xxzenRbBA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>RET抑制剂-肺癌精准靶向新贵</title>
    <updated>2020-09-07T20:23:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-09-07:/s/Oe48AxhXRl4LsgZYLPC5IA</id>
    <link href="https://mp.weixin.qq.com/s/Oe48AxhXRl4LsgZYLPC5IA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>用Outlook订阅新临床试验推送？这么做就对了</title>
    <updated>2020-09-03T13:18:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-09-03:/s/JI0wKEiRJc_T1vljfzBuOg</id>
    <link href="https://mp.weixin.qq.com/s/JI0wKEiRJc_T1vljfzBuOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 ESMO — GI的狂欢</title>
    <updated>2020-09-02T19:50:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-09-02:/s/4yahhZla0HO1FoiwIJxmMQ</id>
    <link href="https://mp.weixin.qq.com/s/4yahhZla0HO1FoiwIJxmMQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>